More Business Wire
View Older Stories View Newer Stories-
LDRA Celebrates 50 Years Leading Embedded Software Quality
-
AGC Biologics Honored by Customers and Industry Leaders for Excellence in Contract Development and Manufacturing
-
Strategy Announces $21 Billion STRK At-The-Market Program
-
Semtech Launches LoRa Plus™ LR2021 Transceiver with LoRa® Gen 4 Technology
-
Detectify Revolutionizes Vulnerability Assessments with Fully Autonomous AI-Built Security Tests
-
Kymeta Goshawk™ u8 Enters Global Market as European Allies Face Growing Defense Pressures
-
Ventus Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating VENT-02, an Oral, Brain-Penetrant NLRP3 Inhibitor, in Parkinson’s Disease
-
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
-
Concentra Acquires Physicians Health Center and OM Management
-
Xerox Empowers High-Performance Partnerships at 2025 Global Partner Summit
-
Verus Mortgage Capital Maintains Leadership as a Top Non-Agency RMBS Issuer in 2024
-
Renesas Releases Certified PROFINET-IRT and PROFIdrive Software Stacks for RZ/T and RZ/N Series Microprocessors
-
ECFC Hosts Advocacy Summit 2025 Featuring Capitol Hill Visits to Discuss Tax-Advantaged Benefits
-
Nautica Unveils Fragrance Line for Women Starring American Actress and YouTuber, Lily Chee
-
Westlake Royal Building Products™ Responds to Trends With New Black Frame Option for Legacy Window Line
-
FIS Launches Treasury GPT, a Pioneering AI-based Product Support Tool for the Treasury Industry
-
C.J. Driscoll & Associates Releases New In-Depth Study of the U.S. Commercial Telematics Systems Market
-
Arbor Day Foundation Leads in Retired Carbon Credits Among Nonprofits
-
Corey Gustafson to Retire as President & CEO of GHK Capital-Backed JohnsByrne; Kevin Andrews Appointed as Successor
-
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
-
Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors
-
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
-
Primaris REIT Provides HBC Exposure Update
-
Net Power Reports Fourth Quarter 2024 Results and Provides Business Update
-
Arrowhead Pharmaceuticals Announces Topline Results from Part 2 of Phase 1/2 Study of ARO-C3 in Patients with IgA Nephropathy
-
Oakbridge Insurance Appoints John Ledyard as Chief Operating Officer
-
Pondurance® Launches New Platform Providing Unified Experience for Managed Detection and Response (MDR)
-
MITER Foundation Now Accepting Applications for Scholarship Program
-
Sunnova Names Paul Mathews as President and Chief Executive Officer
-
Gateway Academy Receives Prestigious WASC Accreditation
-
Care Access Announces Acquisition of Centro Multidisciplinar de Estudos Clínicos (CEMEC), a Leading Brazil-Based Clinical Research Center
-
Subway® Canada Celebrates National Sauce Month by Uncovering Canadians’ Saucy Habits and Behaviours
-
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
-
ZYUS Life Sciences Corporation Announces Close of Unsecured Loan and Amendment to Prior Unsecured Loans
-
New LDC Report Highlights Billion-Dollar Opportunities for Hollywood by Engaging Latino Audiences
-
Celsius Holdings to Participate in Upcoming Investor Conferences
-
KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
-
QAD Appoints Sanjay Brahmawar as New CEO
-
Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference
-
Ingo Payments Partners with Securely to Deliver Real-Time Merchant Settlements with Advanced Ledgering and Payment Capabilities
-
Intelsat and MaxIQ Space Expand STEM Learning to Educators in Multiple African Countries
-
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
-
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
-
Dollar General Announces New Spring Dolly Parton Line
-
Eaton Names Sergio Letelier Senior Vice President, Corporate Development, Planning and Strategy
-
Triton International Announces Agreement to Acquire Global Container International
-
CGD Announces Breakthrough 100Kw+ Technology Enabling GaN to Address $10B+ EV Inverter Market
-
nVent to Acquire the Electrical Products Group Business of Avail Infrastructure Solutions
-
Seoul Medical Group (SMG) and Korean American Medical Group (KAMG) Merge to Form a Leading National Independent Physician Association
